{"DataElement":{"publicId":"2181883","version":"2","preferredName":"Corticosteroid Administered Yes No Unknown Indicator","preferredDefinition":"the yes/no/unknown indicator that asks whether the patient is receiving corticosteroids.","longName":"CORTICO_ADM_IND3","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3431181","version":"1","preferredName":"Corticosteroid Administered","preferredDefinition":"The administration of corticosteroids to the patient.","longName":"CORTICO_ADM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2452713","version":"1","preferredName":"Corticosteroid","preferredDefinition":"Hormones synthesized in the cortex of the adrenal gland and consist of two subclasses, glucocorticoids (carbohydrate regulation) and mineralocorticoids (electrolyte regulation).(NCI)","longName":"C2322","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Corticosteroid","conceptCode":"C2322","definition":"Hormones synthesized in the cortex of the adrenal gland and consist of two subclasses, glucocorticoids (carbohydrate regulation) and mineralocorticoids (electrolyte regulation).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D052842-7E94-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-24","modifiedBy":"ONEDATA","dateModified":"2006-02-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCCBC2C0-E3D0-2D9B-E040-BB89AD436F5F","latestVersionIndicator":"Yes","beginDate":"2012-04-03","endDate":null,"createdBy":"EGANK","dateCreated":"2012-04-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506034","version":"1","preferredName":"Yes No Unknown Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.","longName":"YES_NO_UNKNOWN_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"7","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D05-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D0F-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3241403","version":"1","preferredName":"Unknown","longName":"3241403","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4499CFB-7A3A-DD4D-E040-BB89AD4307BF","latestVersionIndicator":"Yes","beginDate":"2011-05-27","endDate":null,"createdBy":"DWARZEL","dateCreated":"2011-05-27","modifiedBy":"MMADDINENI","dateModified":"2023-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D1A-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2548260","version":"1","preferredName":"Ind-3","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no/unknown.","longName":"C38148","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes, No, or Unknown Response","conceptCode":"C38148","definition":"A response or indicator that can have a value of yes, no, or unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"23801A33-5B13-534B-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2006-11-30","endDate":"2016-04-27","createdBy":"BIRNBAUA","dateCreated":"2006-11-30","modifiedBy":"TAYLORT","dateModified":"2020-10-02","changeDescription":"10.2.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Retired DBW 4-27-2016 per Tina Taylor approved by Dianne Reeves","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C379D9D0-6CF1-CCDD-E040-BB89AD432590","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TITARENI","dateModified":"2021-09-14","changeDescription":"3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. 3/35/2016 jk removed \"indeterminate\" value that was added in error. 7/7/2021wz: added ALT VM name for HOPE-CARE project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811949","version":"1","longName":"Brain","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812015","version":"1","longName":"Metastatic Brain","context":"CTEP"},{"publicId":"2812013","version":"1","longName":"Primary Brain New","context":"CTEP"},{"publicId":"2812014","version":"1","longName":"Primary Brain Recurr","context":"CTEP"}]},{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964910","version":"1","longName":"2117r1: Amyloidosis Post-HSCT Data","context":"NHLBI"},{"publicId":"2964895","version":"1","longName":"2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964889","version":"1","longName":"2017r1: Amyloidosis Pre-HSCT Data","context":"NHLBI"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"},{"publicId":"3303197","version":"1","longName":"Phase 1/Pilot Consortium","context":"COG"}]},{"publicId":"3314514","version":"1","longName":"Under Review","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"3428274","version":"1","longName":"E2410","context":"ECOG-ACRIN"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685478","version":"1","longName":"Testing Set â€“ Moderately Different","context":"NCIP"}]}],"AlternateNames":[{"name":"CLLP_LTHM_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CORT_ADMIN_YN","type":"Context Short Name","context":"CTEP"},{"name":"NHLBI","type":"USED_BY","context":"NHLBI"},{"name":"Alliance","type":"USED_BY","context":"Alliance"},{"name":"CORTICO_ADM_IND3","type":"USED_BY","context":"CTEP"},{"name":"CORTICO_ADM_IND3","type":"USED_BY","context":"COG"},{"name":"LYMpre_therapy_multi_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CORTICO_ADM_IND3","type":"USED_BY","context":"NRG"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"CCR","type":"USED_BY","context":"CCR"},{"name":"mye_post_tx_crtcdstrd_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"MDSpre_therapy_multi_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"mds_base_tx_crtcstrds_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PCDpost_therapy_multi_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PCDpre_therapy_multi_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CORTICO_ADM_IND3","type":"USED_BY","context":"CITN"},{"name":"mye_base_tx_crtcdstrd_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"MACpre_therapy_multi_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"MACpost_therapy_multi_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_ES_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PDDpre_therapy_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PDDpost_therapy_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"RITNfup_thrpy_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"RITNbase_thrpy_m_cortico_ynu","type":"NMDP_FN","context":"NHLBI"},{"name":"CPST_CRS_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CLLF_DRPI_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLP_LTHM_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"PerformedSubstanceAdministration:negationIndicator","type":"HCT_BRIDG_5","context":"CTEP"}],"ReferenceDocuments":[{"name":"COG_CRF_TEXT_2","type":"Alternate Question Text","description":"Did patient require treatment with corticosteroids","url":null,"context":"CTEP"},{"name":"Is the patient receiving cort","type":"Preferred Question Text","description":"Is the patient receiving corticosteroids?","url":null,"context":"CTEP"},{"name":"Corticosteroids","type":"Alternate Question Text","description":"Corticosteroids","url":null,"context":"NHLBI"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Current use of corticosteroids","url":null,"context":"CTEP"},{"name":"Was the recipient treated with corticosteroids prior to HSCT?","type":"Alternate Question Text","description":"Was the recipient treated with corticosteroids prior to HSCT?","url":null,"context":"NHLBI"},{"name":"ACRIN Text","type":"Alternate Question Text","description":"Is the participant currently being treated with corticosteroids","url":null,"context":"ECOG-ACRIN"},{"name":"CRF Text1","type":"Alternate Question Text","description":"No systemic or inhaled corticosteroids or immunosuppressive therapy within 30 days prior to initiation of protocol therapy (NOTE: Use of topical corticosteroids and/or eye drops containing glucocorticosteroids is acceptable.)","url":null,"context":"CTEP"},{"name":"COG_CRF_TEXT_1","type":"Alternate Question Text","description":"Is patient receiving chronic systemic corticosteroids","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Have corticosteroids been discontinued from 7 days prior to first dose of study drug (topical, inhaled or nasal corticosteroids are permitted)?","url":null,"context":"CTEP"},{"name":"CRF Text 6","type":"Alternate Question Text","description":"Chronic systemic or regular inhaled corticosteroid use within 7 days prior to initiation of protocol therapy.","url":null,"context":"CTEP"},{"name":"Corticosteroids","type":"Application Standard Question Text","description":"Corticosteroids","url":null,"context":"NHLBI"},{"name":"CRF text 7","type":"Alternate Question Text","description":"Is the patient on a corticosteroid dose greater than physiologic replacement dosing","url":null,"context":"NRG"},{"name":"PBTC_Text1","type":"Alternate Question Text","description":"Does the site understand that the patient may take therapeutic doses of steroids during the initial dose escalations & prior to defining a recommended phase II dose?  (This should be recorded in the database.  Once the RP2D has been established, enrollment may be limited based on steroid use.  *Physiologic replacement doses will be defined on this protocol as no more than 0.75 mg/m2/day of dexamethasone or equivalent of steroids.  Doses higher than this will be considered therapeutic.)","url":null,"context":"PBTC"},{"name":"COG_CRF_TEXT_3","type":"Alternate Question Text","description":"Has the patient received systemic corticosteroids within the indicated period?","url":null,"context":"COG"},{"name":"COG_CRF_TEXT_4","type":"Alternate Question Text","description":"Is the patient receiving corticosteroids","url":null,"context":"COG"},{"name":"Steroids","type":"Alternate Question Text","description":"Steroids","url":null,"context":"NHLBI"},{"name":"PBTC_Text2","type":"Alternate Question Text","description":"Has patient been on chronic (>1week) immunosuppressive therapy, including corticosteroids (with the exception of physiologic replacement) at the time of enrollment?","url":null,"context":"PBTC"},{"name":"PBTC_Text3","type":"Alternate Question Text","description":"Has patient been on immunosuppressive therapy, including corticosteroids (with the exception of physiologic replacement, defined as 0.75 mg/m2/day) at the time of enrollment?","url":null,"context":"PBTC"},{"name":"Did the recipient receive corticosteroids?","type":"Alternate Question Text","description":"Did the recipient receive corticosteroids?","url":null,"context":"NHLBI"},{"name":"CCTG - 1","type":"Alternate Question Text","description":"Have any Steroid medications been started or stopped this reporting period?","url":null,"context":"CCTG"},{"name":"CRF TEXT 8","type":"Alternate Question Text","description":"Has the patient received systemic dexamethasone continuously at a dose > 8 mg/day for 8 weeks (56 days) prior to registration","url":null,"context":"NRG"},{"name":"COG CRF Text 5","type":"Alternate Question Text","description":"Did patient require treatment with corticosteroids during this reporting period?","url":null,"context":"COG"},{"name":"CRF TEXT 9","type":"Alternate Question Text","description":"Has the patient received steroid treatment beyond a maximum of 8 mg/day of dexamethasone (or equivalent) or a total of 8 weeks (56 days) prior to registration","url":null,"context":"NRG"},{"name":"CRF TEXT 10","type":"Alternate Question Text","description":"Was the patient on any dose of any systemically administered (oral, rectal, intravenous) corticosteroid within 3 days prior tostep 2 registration","url":null,"context":"NRG"},{"name":"COG CRF Text 100","type":"Alternate Question Text","description":"Is the patient receiving a dose of corticosteroid that is not allowed according to the eligibility criteria for this protocol?","url":null,"context":"COG"},{"name":"COG CRF Text 12","type":"Alternate Question Text","description":"Did patient require treatment with pharmacologic doses of corticosteroids during this reporting period?","url":null,"context":"COG"},{"name":"NRG CRF TEXT13","type":"Alternate Question Text","description":"Has the patient received dexamethasone or other systemic corticosteroids, to treat brain edema and/or brain edema-related symptoms, at a dose greater than 2 mg of dexamethasone (or equivalent) daily within 5 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG CRF TEXT12","type":"Alternate Question Text","description":"Is the patient recieving dexamethasone or other systemic corticosteroids, to treat brain edema and/or brain edema-related symptoms, at a dose greater than 2 mg of dexamethasone (or equivalent) daily for less than 5 days prior to registration?","url":null,"context":"NRG"},{"name":"CRF Text 11","type":"Alternate Question Text","description":"If the patient is receiving dexamethasone or other systemic corticosteroids for brain edema or brain edema symptoms, is the dose less than or equal to 2mg of dexamethasone (or equivalent) daily for a minimum of 5 days prior to registration?","url":null,"context":"NRG"},{"name":"CRF Text12","type":"Alternate Question Text","description":"Is the patient currently using adrenal steroids?","url":null,"context":"Alliance"}],"origin":"Brain CDE Disease Committee","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C521FD4A-1C71-FC5E-E040-BB89AD43363B","latestVersionIndicator":"Yes","beginDate":"2012-07-18","endDate":null,"createdBy":"DWARZEL","dateCreated":"2012-07-18","modifiedBy":"DWARZEL","dateModified":"2022-05-24","changeDescription":"Replace VD Therapy Ind-3 2018278v2.0 with VD ID#3506034 - Yes No Unknown Indicator, set wfs \"Released\", create new whole number version, effective begin date 7/18/2012  - dbw; Added HCT_BRIDG5 alternate name - RR 2018-12-23","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}